Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
JOHNSON & JOHNSON | JNJ | Buenos Aires S.E. +1 Other | 9,705 | 11,140 ARS | Stock | |
JOHNSON & JOHNSON | JNJD | Buenos Aires S.E. | 435 | 10.6 USD | ||
JOHNSON & JOHNSON | JNJ | Nyse +17 Other | 7,345,979 | 152.7 USD | Stock | |
JOHNSON & JOHNSON | 000943981 | Berne S.E. | - | 136.3 CHF | ||
JOHNSON & JOHNSON | JNJ | Deutsche Boerse AG | 1,069 | 139.9 EUR | ||
JOHNSON & JOHNSON | JNJ * | Mexican S.E. | 1,861 | 2,549 MXN | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 136 USD | ||
JOHNSON & JOHNSON | JNJ | Frankfurt | 3,420 | 139.5 EUR | ||
JOHNSON & JOHNSON | JNJ | Wiener Boerse | 35 | 139.6 EUR | ||
JOHNSON & JOHNSON | 0R34 | London S.E. | 1,234 | 149.3 USD | ||
JOHNSON & JOHNSON | JNJ | Börse Stuttgart | 585 | 139.9 EUR | ||
JOHNSON & JOHNSON | JNJ | Bolsa De Valores De Colombia | 12 | 5,87,980 COP | ||
JOHNSON & JOHNSON | JNJ | Lima | - | 144.5 USD | ||
JOHNSON & JOHNSON | JNJ | Santiago S.E. | - | 148.3 USD | ||
JOHNSON & JOHNSON | JNJ | BOERSE MUENCHEN | 2,893 | 140.6 EUR | ||
JOHNSON & JOHNSON | 4JNJ | Borsa Italiana | - | 139.6 EUR | ||
JOHNSON & JOHNSON | JNJ | Bulgaria S.E. | 6 | 138.7 EUR | ||
JOHNSON & JOHNSON | JNJCL | Santiago S.E. | - | 1,55,930 CLP | ||
JOHNSON & JOHNSON | JNJ_KZ | Kazakhstan S.E. | 13 | 152.1 USD | ||
JOHNSON & JOHNSON | JNJ | Swiss Exchange | - | 500 CHF | ||
JOHNSON & JOHNSON | JNJB34 | Sao Paulo | 6,879 | 52.27 BRL | Stock | |
JOHNSON & JOHNSON | JNJ0 | Deutsche Boerse AG +1 Other | - | 13.3 EUR | Stock | |
JOHNSON & JOHNSON | JNJ | NEO Exchange | 6,727 | 20.48 CAD | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI | Nyse +7 Other | 6,167,295 | 68.18 USD | Stock | |
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Deutsche Boerse AG | 102 | 61.34 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | JCI1 N | Mexican S.E. | 0 | 1,003 MXN | ||
JOHNSON CONTROLS INTERNATIONAL PLC | 0Y7S | London S.E. | 5,595 | 67.13 USD | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Börse Stuttgart | - | 62.41 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | BOERSE MUENCHEN | 91 | 62.54 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Frankfurt | 22 | 53.62 EUR | ||
JOHNSON CONTROLS INTERNATIONAL PLC | TYIA | Berne S.E. | - | - CHF | ||
JOHNSON PHARMACARE LIMITED | SUNSHINE6 | Bombay S.E. | 1,469,520 | 1 INR | Stock | |
JOHNSON OUTDOORS INC. | JOUT | Nasdaq | 71,131 | 37.57 USD | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | Bombay S.E. +1 Other | 27,389 | 151.3 INR | Stock | |
PRISM JOHNSON LIMITED | PRSMJOHNSN | NSE India S.E. | 384,673 | 152.1 INR | ||
JOHNSON MATTHEY PLC | JMPLY | OTC Markets | 1,912 | 47.42 USD | Stock | |
JOHNSON MATTHEY PLC | JMAT | London S.E. +6 Other | 378,665 | 1,861 GBX | Stock | |
JOHNSON MATTHEY PLC | JMT2 | Deutsche Boerse AG | - | 21.48 EUR | ||
JOHNSON MATTHEY PLC | JMAT N | Mexican S.E. | - | 811 MXN | ||
JOHNSON MATTHEY PLC | JMT2 | Börse Stuttgart | - | 21.68 EUR | ||
JOHNSON MATTHEY PLC | JMT2 | BOERSE MUENCHEN | 273 | 22.18 EUR | ||
JOHNSON MATTHEY PLC | JMPLF | OTC Markets | 912 | 23.3 USD | ||
JOHNSON MATTHEY PLC | JMAT | Berne S.E. | - | - CHF |
News (862)
Companies (50)
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, ...
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-ca ...
Allegion plc specializes in manufacturing and marketing security systems. Products are sold under the Cisa, Interflex, LCN, Schlage, Von Duprin, Aptiq, Bocom, Briton, Bricard, Dexter, Falcon, Glynn-Johnson, Ito Kilit, Ives, Kryptonite, Legge, Normbau, Ste ...
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: ...
Johnson Controls International Plc specializes in the design, manufacturing and marketing of equipment for the regulation and safety of buildings. Net sales break down by family of products and services as follows: - building regulation, integrated manag ...
Prism Johnson Limited is an India-based building materials company. The Company operates through four segments: Cement, Tile and Bath (HRJ), and Ready Mixed Concrete (RMC). The Cement segment has a cement production capacity of 5.6-meganewton tons at Satn ...
Johnson Service Group PLC provides textile rental and related services across the United Kingdom and the Republic of Ireland. The Company's Workwear business is a supplier of workwear and protective wear in the United Kingdom, offering these services thro ...
Insiders
Clive Thomas Johnson founded B2Gold Corp. Presently, he occupies the position of Chairman at Vanadian Energy Corp. and President, Chief Executive Officer & Director at B2Gold Corp. Mr. Johnson is also on the board of BeMetals Corp. (former Chairman). Mr. Johnson previously occupied the position of Chairman, President & Chief Executive Officer at EastWest Gold Corp.
Clive Alan Hatchard is the founder of Spectrum Corporate Finance Ltd., where he holds the title of Joint Managing Director since 2010.
He is currently working at Ernst & Young LLP since 2004.
In the past, he worked as the Chief Financial Officer at Land of Leather Holdings Plc.
Clive Royston Watson is the founder of The Capital Pub Co. Ltd.
(2000), Tup Inns Ltd.
(1998), and The City Pub Group Plc (2011).
He held the title of CEO & Director at The Capital Pub Co. Ltd.
(2010-2011) and CEO at Tup Inns Ltd.
(1998-1999).
He currently holds the position of Director at The City Pub Company (West) Ltd.
(since 2011).
Mr. Watson's former positions include CEO at Greene King Ltd., Secretary & Finance Director at Regent Inns Plc (1998), and Non-Executive Director at Eclectic Bar Group Plc (2013-2015).
Mr. Watson is also the founder of Tom Hoskins Plc.
Clive Richard is the founder of LawBit Ltd.
He currently holds the titles of Chairman and Chief Executive Officer at the company, which was founded in 2011.
No results for this search
- Stock Market
- Advanced search
- Clive Johnson